Quarterly report pursuant to Section 13 or 15(d)

Statements of Cash Flows (unaudited)

v3.24.2.u1
Statements of Cash Flows (unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (5,963,368) $ (3,941,506)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 606,842 262,437
Increase (decrease) in cash resulting from changes in:    
Prepaid expenses and other current assets 367,802 428,843
Accounts payable 360,253 (58,924)
Accrued and other current liabilities (201,936) (180,848)
Total adjustments to reconcile net loss to net cash used in operations 1,132,961 451,508
Net cash used in operating activities (4,830,407) (3,489,998)
Cash flows from financing activities:    
Proceeds from issuance of Common Stock and warrants, net of issuance costs 2,410,200 5,687,087
Issuance costs paid setting up ATM (70,000) 0
Proceeds from exercise of pre-funded warrants 0 187
Payment for fractional shares in reverse stock split (828) (40)
Net cash provided by financing activities 2,339,372 5,687,234
Net increase (decrease) in Cash and cash equivalents (2,491,035) 2,197,236
Cash and cash equivalents at beginning of period 7,438,135 6,241,294
Cash and cash equivalents at end of period 4,947,100 8,438,530
Non-cash financing activities:    
Issuance of abeyance shares (18) 0
Incremental fair value of May 2024 warrant inducement 1,526,232 0
Equity issuance costs in accounts payable or accrued expenses 89,737 0
Deferred offering costs included in accounts payable and accrued expenses 46,755 0
Incremental fair value of March 2023 warrant modification   144,765
Supplemental disclosure:    
Cash paid for taxes $ 950 $ 950